Nothing Special   »   [go: up one dir, main page]

JPS59190226A - Bivalent and trivalent iron salt and their preparation - Google Patents

Bivalent and trivalent iron salt and their preparation

Info

Publication number
JPS59190226A
JPS59190226A JP58064298A JP6429883A JPS59190226A JP S59190226 A JPS59190226 A JP S59190226A JP 58064298 A JP58064298 A JP 58064298A JP 6429883 A JP6429883 A JP 6429883A JP S59190226 A JPS59190226 A JP S59190226A
Authority
JP
Japan
Prior art keywords
trivalent iron
divalent
bivalent
salts
trivalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58064298A
Other languages
Japanese (ja)
Other versions
JPH0427171B2 (en
Inventor
Shoji Yamashita
昭治 山下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP58064298A priority Critical patent/JPS59190226A/en
Publication of JPS59190226A publication Critical patent/JPS59190226A/en
Priority to JP1270700A priority patent/JPH0761875B2/en
Publication of JPH0427171B2 publication Critical patent/JPH0427171B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cultivation Of Plants (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Iron (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To prepare a bivalent and a trivalent iron salts having physiological actions such as an inhibitory action on various kinds of ions, antiviral action, carcinostatic action, immunizing action, etc., by adding a trivalent iron salt to a large amount of an aqueous solution of a strong acid. CONSTITUTION:For example, a trivalent iron salt such as FeCl3, etc. is added to a large amount of aqueous solution of strong alkali, dissolved in it by stirring, and allowed to stand. The formed insoluble substances are filtered off, the filtrate is neutralized with an acid, concentrated under reduced pressure, dried and crystallized. An aqueous solution of alcohol is added to the crystal, the soluble component is collected, concentrated under reduced pressure to remove the solvent, and dried. These operations of extraction-concentration-drying are repeated several times, to prepare high-purity bivalent and trivalent iron salts. The bivalent and trivalent salts are inorganic or organic acid salts of iron showing properties between those of bivalent and trivalent iron salts.

Description

【発明の詳細な説明】 本発明は各種イオン反応の抑制作用、更には抗ウィルス
作用、抗癌作用、免疫作用等の生理作用を有する二価三
価鉄塩に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a divalent and trivalent iron salt having an inhibitory effect on various ion reactions and also has physiological effects such as an antiviral effect, an anticancer effect, and an immunological effect.

既存の二価三価鉄化合物として公知のものは四三酸化鉄
があるが、二価三価鉄塩゛は本発明によって新規に提供
されるものである。そして上記二価三価鉄塩は水に溶解
して該水を非イオン反応系に変換し、各種のイオン反応
を抑制して通常の水系におけるイオン反応による場合と
は著るしく異なる反応を訪導することが判明した。そし
て正常な生体内反応はすべて上記二価三価鉄塩によって
形成せられると同種な非イオン反応系で行われているこ
とは明らかである。そこで異常な生体に二価三価鉄塩を
導入すれば生体内の非イオン反応系が回復し、生体は正
常に復帰することが出来る。かくして本発明の二価三価
鉄塩はイオン反応抑制作用にもとづく金属腐蝕抑制作用
、塩障害除去作用、土壌障害除去作用に加えて防腐作用
、抗ウィルス作用、抗癌作用、免疫作用等の生理作用を
も有するものである。
A known existing divalent and trivalent iron compound is triiron tetroxide, but a divalent and trivalent iron salt is newly provided by the present invention. The divalent and trivalent iron salts dissolve in water, converting the water into a nonionic reaction system, suppressing various ionic reactions, and leading to reactions that are significantly different from those caused by ionic reactions in ordinary aqueous systems. It turned out to be a guide. It is clear that all normal in-vivo reactions take place in the same type of nonionic reaction system formed by the above-mentioned divalent and trivalent iron salts. Therefore, if divalent and trivalent iron salts are introduced into an abnormal living body, the nonionic reaction system within the living body will be restored, and the living body will be able to return to normal. Thus, the divalent and trivalent iron salt of the present invention has physiological effects such as antiseptic action, antiviral action, anticancer action, and immunological action in addition to metal corrosion inhibiting action, salt damage removal action, and soil damage removal action based on ionic reaction inhibition action. It also has a function.

本発明の二価三価鉄塩は二価鉄と三価鉄との中間の性質
を示す鉄の塩酸塩、硫酸塩、燐酸塩、硝酸塩等の無機塩
、蟻酸塩、酢酸塩、プロピオン酸塩等の有機塩であシ、
三価鉄の塩類を多量のカセインーダ、水酸化カリウム、
水酸化リチウム、水酸化カルシウム等の強アルカリの水
溶液に投入して二価鉄への原子価変換を起させた場合、
二価鉄の塩類を多量の塩酸、硫酸等の強酸の水溶液に投
入して三価鉄への原子価変換を起させた場合の遷移形態
として得られるものである。以下に二価三価鉄塩の製造
方法の具体例を示す。
The divalent and trivalent iron salts of the present invention are inorganic salts such as hydrochlorides, sulfates, phosphates, and nitrates, formates, acetates, and propionates of iron, which exhibit intermediate properties between divalent iron and trivalent iron. Organic salts such as
Large amounts of trivalent iron salts, caseinida, potassium hydroxide,
When placed in a strong alkali aqueous solution such as lithium hydroxide or calcium hydroxide to cause valence conversion to divalent iron,
It is obtained as a transition form when salts of divalent iron are added to a large amount of an aqueous solution of a strong acid such as hydrochloric acid or sulfuric acid to cause valence conversion to trivalent iron. Specific examples of the method for producing divalent and trivalent iron salts are shown below.

■、二価鉄塩より 1.0りの塩化第二鉄(FeCl 3・6H20)を1
00m1の0.5Nカセイソーダ水溶液中に投入し7攪
拌溶解した後−夜装置する。生じた不溶性物質を涙別I
−沖液を塩酸で中和し7た後減圧濃縮してデシケータ−
中で乾燥結晶化する1、かくして塩化ナトリウムに担持
された二価三価鉄の塩化物(以下塩化鉄(n、ITJ)
と云うンが得られるが、該担持物から塩化鉄(IL]’
iT)を分離するには更に50m7のインプロビルアル
コール80%水溶液を加えて溶出成分を集め、減圧濃縮
し溶媒を除去、乾燥はせる。上記抽出−m、縮−乾燥操
作を数回繰返すことによって0.25Flの塩化鉄(T
i、m)が得られる○2、三価鉄塩より 1.0#硫酸第一鉄(FeSO47”/H20)を10
0ytの0.5 N塩酸水溶液中に投入し攪拌溶解した
後−夜装置する。生じた不溶性物質を炉別り、P液を減
圧濃縮しデシケータ中で乾燥する。得られた乾燥粉末に
10dのイソプロパツール80チ水溶液を加えて溶出成
分を集め、減圧濃縮し溶媒を除去、乾燥させる。上記抽
出−濃縮−乾燥操作を数回繰返すことによって0.fl
pの塩化鉄(I[、ITI)が得られる。
■, 1.0 ferric chloride (FeCl 3.6H20) from divalent iron salt
The mixture was poured into 0.00ml of 0.5N caustic soda aqueous solution, stirred for 7 hours to dissolve, and then set aside overnight. The resulting insoluble substances are classified into tears.
- Neutralize the Oki liquid with hydrochloric acid, then concentrate under reduced pressure and place in a desiccator.
The chloride of divalent and trivalent iron (hereinafter referred to as iron chloride (n, ITJ)) is thus supported on sodium chloride.
Iron chloride (IL)' is obtained from the support.
To separate iT), 50 m7 of an 80% aqueous Improvil alcohol solution is added, the eluted components are collected, concentrated under reduced pressure to remove the solvent, and dried. By repeating the above extraction-m and condensation-drying operations several times, 0.25Fl of iron chloride (T
i, m) are obtained ○2, 1.0# ferrous sulfate (FeSO47"/H20) from trivalent iron salt 10
0 yt of 0.5N aqueous hydrochloric acid solution, stirred and dissolved, and then set up overnight. The resulting insoluble substances are separated in a furnace, and the P solution is concentrated under reduced pressure and dried in a desiccator. To the obtained dry powder is added 10 d of an aqueous solution of isopropanol, the eluted components are collected, concentrated under reduced pressure to remove the solvent, and dried. By repeating the above extraction-concentration-drying operation several times, the fl
Iron chloride (I[, ITI) of p is obtained.

本発明の二価三価鉄塩は例えば塩化ナトリウム、硫酸ナ
トリウム、塩化アンモニウム、硫酸アンモニウム、珪藻
土、ベントナイト、シリカ、アルミナ等の無機化合物、
ビタミン、ホルモン、蛋白質、脂質等の有機化合物に担
持されてもよく、その場合においても二価三価鉄塩の作
用は変化することがない。
The divalent and trivalent iron salts of the present invention include inorganic compounds such as sodium chloride, sodium sulfate, ammonium chloride, ammonium sulfate, diatomaceous earth, bentonite, silica, alumina, etc.
It may also be supported on organic compounds such as vitamins, hormones, proteins, and lipids, and even in that case, the action of the divalent and trivalent iron salt does not change.

以下に本発明の実施例を示す。Examples of the present invention are shown below.

実施例1(金属の防蝕) 本実施例は本発明にか\る二価三価鉄の防蝕作用を示す
ものである。金属の腐蝕は金属表面で同種金属間または
異種金属間に腐蝕電流が生ずることによって起る。従っ
て金属を二価三価鉄を含む溶液で表面処理をすることに
よって防蝕゛をはかることができる。
Example 1 (Corrosion protection of metal) This example shows the corrosion protection effect of divalent and trivalent iron according to the present invention. Corrosion of metals occurs due to the generation of corrosion current between similar or dissimilar metals on the metal surface. Therefore, corrosion protection can be achieved by surface treating metals with a solution containing divalent and trivalent iron.

0.2cMX5σX5oxの鉄片を予かしめ稀塩酸およ
び蒸留水で洗浄・乾燥させた後、塩化鉄(II、Irf
)(2,5X 1.0−5g/lit ) 、弗化水素
酸(1,2X10’f/ml)およびglucose 
(10g/nl )(D混合溶液200ゴ中に入れ、8
0℃で30分間処理した。
After precaulking an iron piece of 0.2cMX5σX5ox and washing and drying it with dilute hydrochloric acid and distilled water,
) (2,5X 1.0-5g/lit), hydrofluoric acid (1,2X10'f/ml) and glucose
(10g/nl) (Pour into 200g of D mixed solution, 8g/nl)
It was treated at 0°C for 30 minutes.

処理した鉄片をHCI気流中で腐蝕試験を行なったとこ
ろ、無処理の鉄片は1時間後に既に顕著な腐蝕をみたが
、処理鉄片は6日間の腐蝕試験によっても腐蝕をみなか
った。
When the treated iron piece was subjected to a corrosion test in an HCI air stream, the untreated iron piece already showed significant corrosion after one hour, but the treated iron piece showed no corrosion even after a 6-day corrosion test.

実施例2(塩障害の除去ン 本実施例は本発明の二価三価鉄の塩障害除去作用を示す
ものである。電解質溶液とくに海水は含有する金属イオ
ンのために船舶や海上、沿岸諸産業に多大の障害をもた
ら17ている。二価三価鉄の適用によってこれらの障害
を除去することができる0 天然海水に10−12g/Itになるように塩化鉄(n
、I[[)を加え、これに鉄粉、マンガン粉、銅粉を添
加し静置したところ、無処理海水では1日以内にすべて
塩化物を生じたが、処理海水では1年以上変化が起らな
かった。
Example 2 (Removal of salt damage) This example shows the salt damage removal effect of divalent and trivalent iron of the present invention. Electrolyte solutions, especially seawater, are harmful to ships, seas, and coastal areas due to the metal ions they contain. These obstacles can be removed by the application of divalent and trivalent iron.0 Iron chloride (n
When , I [ It didn't happen.

実施例3(連作障害土壌の改質) 本実施例は本発明の二価三価鉄の連作障害土壌の改質作
用を示すものである。同一作物を連作していくと作物に
よっては土壌中に病原菌の繁殖が烈しく起り殆ど収穫不
能に陥ることがある。その根本原因は土壌中に集積する
無機、有機物質のイオン反応によるものである。従って
二価三価鉄化合物の導入によってこれらの障害を除去す
ることができる。
Example 3 (Improvement of continuous cropping impaired soil) This example shows the effect of improving continuous cropping impaired soil with divalent and trivalent iron of the present invention. If the same crop is continuously cultivated, pathogenic bacteria may proliferate in the soil depending on the crop, making it almost impossible to harvest. The root cause is ionic reactions between inorganic and organic substances that accumulate in the soil. Therefore, these obstacles can be removed by introducing divalent and trivalent iron compounds.

大根栽培地(岐阜県下)で起った7ザリウムの繁殖を伴
った強度の連作障害土壌にNaClを担体とした塩化鉄
(Il、IIr)を10 1j/lxlになるように水
で希釈し、その希釈液を土が潤う程度に与え、常法通り
大根を作付した。その結果、処理土壌の作物はすべて健
全に生育し、対照区の収11QOに対し、240の収量
指数が得られた。
Iron chloride (Il, IIr) with NaCl as a carrier was diluted with water to a concentration of 10 1j/lxl in soil with severe continuous cropping damage accompanied by the proliferation of 7salium that occurred in a radish cultivation area (under Gifu Prefecture). The diluted solution was applied to the soil to moisten it, and radish was planted as usual. As a result, all the crops in the treated soil grew healthy, and a yield index of 240 was obtained, compared to 11QO in the control plot.

実施例4(生体組織保存) 本実施例は本発明の二価三価鉄の生体組織保存作用を示
すものである。
Example 4 (Biological Tissue Preservation) This example shows the biological tissue preservation effect of divalent and trivalent iron of the present invention.

生体組織は一度生体個体から離れると、生体システムが
破壊されて組織の機能が失われるために蛋白質、炭水化
物等の生体成分は直ちに分解をはじめる。二価三価鉄化
合物は生体システムを成立させる基本物質であるため、
生体組織を生体から切り出1〜だ後でも二価三価鉄化合
物を含む溶液中では組織の崩壊が起らない。
Once a biological tissue is separated from a living individual, biological components such as proteins and carbohydrates immediately begin to decompose because the biological system is destroyed and tissue functions are lost. Since divalent and trivalent iron compounds are basic substances that establish biological systems,
Even after the living tissue is cut out from the living body, tissue disintegration does not occur in a solution containing a divalent and trivalent iron compound.

塩化鉄(1、lit )lo  M溶液10dにα−t
ocopherolおよびUbiquinone (C
o−enz7meQy)各0.11の混合物を加えて懸
濁させた後、ethanalで上記脂質部分を集めた。
α-t in 10d of iron chloride (1, lit) lo M solution
ocopherol and Ubiquinone (C
After adding and suspending a mixture of 0.11 each of o-enz7meQy), the above lipid portion was collected with ethanal.

かくして塩化鉄(l 、 li口を担持する上記脂質が
得られる。この脂質に界面活性剤としてTween−2
00,1f/を加えて水に分散させ、順次蒸溜水で希釈
し脂質濃度で2 X 10  M/Lの調整液を作成し
た。
In this way, the above-mentioned lipid carrying iron chloride (l, li) is obtained.This lipid is treated with Tween-2 as a surfactant.
00,1f/ was added and dispersed in water, and successively diluted with distilled water to prepare an adjusted solution with a lipid concentration of 2 x 10 M/L.

白ネズミを屠殺後、直ちに筋肉組織をビンに入れ、上記
の処理液を加え、一部空気層を残して密栓し常温に静置
した。同時に対照として筋肉組織に蒸留水を加えて密栓
したものを並べて静置した。
Immediately after killing the white rat, the muscle tissue was placed in a bottle, the above treatment solution was added, the bottle was tightly capped leaving some air space, and the bottle was allowed to stand at room temperature. At the same time, as a control, distilled water was added to the muscle tissue and the tissue was sealed and left standing.

その結果、対照区は1週後から組織が崩壊し、微生物が
繁殖して水がはげしく涸渇した。ところが処理区の検体
は組織が崩れず、微生物の繁殖が起らず、液は透明のま
ま12年以上最初の状態を保った。
As a result, the tissue in the control plot collapsed after one week, microorganisms multiplied, and water rapidly dried up. However, the tissue of the samples from the treatment area remained intact, no microbial growth occurred, and the liquid remained clear for more than 12 years.

実施例5←植物組織の再生) 本実施例は本発明の二価三価鉄の植物組織の再生作用を
示すものである。
Example 5 Regeneration of plant tissue) This example shows the regeneration effect of divalent and trivalent iron of the present invention on plant tissue.

二価三価鉄化合物を脂質(α−tocopherol 
+Ubiquinone )を担体として合成し、脂質
濃度で7 10  M/Lの溶液で調整し、その調整液にクロマツ
の切枝を30分浸漬した後、石英砂を入れたポットに挿
木した。対照区はすべて枯死したが、処理したクロマツ
は活着し発根した。
Divalent and trivalent iron compounds are added to lipids (α-tocopherol).
+Ubiquinone) was synthesized as a carrier and adjusted with a solution with a lipid concentration of 7 10 M/L. Cut branches of Japanese black pine were immersed in the adjusted solution for 30 minutes, and then the cuttings were placed in a pot containing quartz sand. All of the control plots died, but the treated black pines took root and took root.

実施例6(生体成分の非生物合成) 本実施例は本発明の二価三価鉄が主体成分を非生物合成
する作用を示すものである。
Example 6 (Abiotic synthesis of biological components) This example shows the effect of the divalent and trivalent iron of the present invention in abiotic synthesis of the main component.

二価三価鉄化合物は生体内で、通常遺伝現象として知ら
れている体蛋白質の生合成に関与している。二価三価鉄
化合物を用いることによって非生物系で任意の蛋白質を
合成することができる。
In vivo, divalent and trivalent iron compounds are involved in the biosynthesis of body proteins, which is generally known as a genetic phenomenon. By using divalent and trivalent iron compounds, any protein can be synthesized in an abiotic system.

1qのインシーリンを含む1%塩化鉄(n、III)水
溶液100ゴから塩化鉄(II、m)を再抽出し、エタ
ノールで洗浄後乾燥精製した。この結晶を溶質とする新
たな水溶液(10−6M)を調整し、ここに0.1gの
シスチンを溶解し、その溶液を蒸溜水を外液とするセル
ロース膜の透析を行なった。
Iron chloride (II, m) was re-extracted from 100 g of a 1% iron chloride (n, III) aqueous solution containing 1 q of incirin, washed with ethanol, and then dried and purified. A new aqueous solution (10-6 M) containing this crystal as a solute was prepared, 0.1 g of cystine was dissolved therein, and the solution was subjected to dialysis through a cellulose membrane using distilled water as an external liquid.

透析チー−ブ内の生成物1oy!Igを採取、結晶させ
、種々の分析を行なったところ、前と同一組成をもつイ
ンシュリンであることが確認された。
1 oy of product in dialysis tube! When the Ig was collected, crystallized, and subjected to various analyses, it was confirmed that it was insulin with the same composition as before.

実施例7(防腐、防黴作用) 本実施例は本発明の二価三価鉄の防腐、防黴作用を示す
ものである。二価三価鉄化合物は微生物に接触するとそ
の微生物の有する情報に従う新たな蛋白質合成機能を獲
得する。この現象は従来、抗原−抗体反応として理解さ
れてきたものである。
Example 7 (Preservative and anti-mold effect) This example shows the anti-septic and anti-mold effect of divalent and trivalent iron of the present invention. When divalent and trivalent iron compounds come into contact with microorganisms, they acquire new protein synthesis functions based on the information possessed by the microorganisms. This phenomenon has conventionally been understood as an antigen-antibody reaction.

この抗体を利用して食品類の防腐、防黴をはかることが
できる。
This antibody can be used to prevent food from becoming preservative and moldy.

塩化鉄(n、l1lr)を塩化マグネシウムを担体とし
て合成し、塩化マグネシウム濃度で1O−6f/xlの
溶液を作り処理液とした。
Iron chloride (n, l1lr) was synthesized using magnesium chloride as a carrier, and a solution with a magnesium chloride concentration of 1O-6f/xl was prepared and used as a treatment liquid.

予かしめアサリおよび餅片を開放系で32℃に3日間静
置し、微生物を繁殖させた。生じた微生物を上記処理液
10m1を入れた試験管中に澱粉およびペプトン各0.
5gと共に入れ、32℃に5日間静置した。生じた懸濁
液0.1ptlを100ゴの水に添加し、この液を新鮮
なアサリおよび餅に雇水し、密封して常温に保存した。
The pre-caulked clams and mochi pieces were left standing at 32°C in an open system for 3 days to allow microorganisms to propagate. The resulting microorganisms were placed in a test tube containing 10ml of the above treatment solution, and 0.0% each of starch and peptone were added.
5g and left at 32°C for 5 days. 0.1 ptl of the resulting suspension was added to 100 grams of water, and this solution was poured over fresh clams and rice cakes, sealed and stored at room temperature.

対照区は何れも腐敗およぎカビの発生をみたが、処理検
体では3週以上微生物の増殖が起らなかった。
In all control plots, rotting and mold growth was observed, but no growth of microorganisms occurred in the treated samples for more than 3 weeks.

実施例8(抗ウィルス作用) 本実施例は本発明の二価三価鉄の抗ウィルス作用を示す
ものである。
Example 8 (Antiviral action) This example shows the antiviral action of divalent and trivalent iron of the present invention.

二価三価鉄化合物によって維持されている生体システム
に対して外部からこれに変更を加える物質または要因が
侵入した場合、ここに生体機能の低下が起りいわゆる病
変となって現われる。ウィルス感染障害は外部から核酸
が持込まれ生体システムが破壊されることによって生ず
るものである。
When a substance or factor that alters the biological system maintained by divalent and trivalent iron compounds invades from outside, the biological function deteriorates and appears as a so-called lesion. Viral infection disorders are caused by the introduction of nucleic acids from the outside and destruction of biological systems.

従って二価三価鉄化合物を効果的に導入することによっ
て感染障害を除去することができる。
Therefore, infectious disorders can be eliminated by effectively introducing divalent and trivalent iron compounds.

予かしめトマトを宿主植物としてトマト葉にTM、Vを
接種、生体増殖させた後、試験直前にトマト葉より汁液
を採取、水で500倍に希釈して試験用TMV懸濁液と
した。
TM and V were inoculated onto tomato leaves using a pre-caulked tomato as a host plant, and the sap was grown biologically. Just before the test, the sap was collected from the tomato leaves and diluted 500 times with water to prepare a test TMV suspension.

約1ケ月後栽培したタバコ植物葉にカーボランダムを塗
布したのち、試験葉の半部に対照としてTMV懸濁液を
水で2倍希釈したもの、同−葉の他の半部にTMV懸濁
液を可検液で2倍希釈したものをそれぞれ綿に浸して塗
布した。可検液としては塩化鉄(II、IIIJIOM
溶液にMg Cl 2−6H20を1%になるように添
加したものを用いた。塗布後葉が乾いたところで(約3
0分後〕残余のカーボランダムを水洗して、26℃のコ
イトトロン中で植物を培養した。
After about 1 month, carborundum was applied to leaves of cultivated tobacco plants, and half of the test leaves were treated with TMV suspension diluted 2 times with water as a control, and the other half of the test leaves were treated with TMV suspension. The solution was diluted 2 times with a testable solution and then soaked in cotton and applied. Testable liquids include iron chloride (II, III JIOM
A solution containing Mg Cl 2-6H20 added to a concentration of 1% was used. When the leaves are dry after application (approximately 3
0 minutes later] The remaining carborundum was washed with water, and the plants were cultured in a coitotron at 26°C.

培養3日後に各試験葉に生じた斑点の数および可検物質
の阻止率を求めた結果は第1表に示す通りであった。
After 3 days of culture, the number of spots that appeared on each test leaf and the inhibition rate of detectable substances were determined, and the results are shown in Table 1.

第1表 塩化鉄(II、In)溶液による ウィルス感染阻止 実施例9(制癌作用) 本実施例は本発明の二価三価鉄の制癌作用を示すもので
ある。悪性腫瘍は、外界からのウィルスあるいは種々の
発癌性物質によって生体システムが極度に破壊され、正
常な細胞が異常細胞へ移行することによってひき起され
る。ここに二価三価合 鉄化騰物を導入することによって生体システムが成立し
異常細胞の増殖を阻止することができる。
Table 1 Inhibition of virus infection by iron (II, In) chloride solution Example 9 (Anticancer effect) This example shows the anticancer effect of divalent and trivalent iron of the present invention. Malignant tumors are caused when biological systems are severely destroyed by viruses or various carcinogenic substances from the outside, and normal cells migrate to abnormal cells. By introducing divalent and trivalent ferrous compounds here, a biological system is established and the proliferation of abnormal cells can be inhibited.

塩化鉄(n、IIT) 10−6M溶液1.Otglに
α−tocopherolおよびUbiquinone
 (Co−enzVmeQ7)各1.0gの混合物を加
えて懸濁させた後、工〃ノールで脂質部分を集めた。か
くして塩化鉄(T’J、m)を担持する上記脂質が得ら
れる。この脂質にTween −200,11i’を加
えた水に分散させ、順次蒸溜水で希釈り、て調整液を作
成し、各濃度の調、整液を基準として5yntheti
c  medium 858の培養液を作成した。各脂
質濃度の培養液でヒトの胃の健全部と癌組織をtryp
sim  消化して得た細胞を24時間培養1〜、その
細胞数を脂質を含督ない培養液で培養した場合の細胞数
を100とする指数であられすと第1図に示す通りであ
った。正常細胞の増殖が起る2X10  Mのところで
異常細胞の明らかな増殖抑制が認められた。
Iron chloride (n, IIT) 10-6M solution 1. α-tocopherol and Ubiquinone in Otgl
(Co-enzVmeQ7) After adding and suspending 1.0 g of each mixture, the lipid portion was collected with ethanol. The above-mentioned lipid carrying iron chloride (T'J, m) is thus obtained. This lipid was dispersed in water with Tween-200.
A culture solution of c medium 858 was prepared. Try culturing healthy parts of the human stomach and cancerous tissues using culture media with various lipid concentrations.
The cells obtained by sim digestion were cultured for 24 hours from 1 to 1, and the number of cells was expressed as an index of 100 when cultured in a culture medium that did not contain lipids, as shown in Figure 1. . Clear inhibition of abnormal cell proliferation was observed at 2×10 M, where normal cell proliferation occurs.

実施例10(制癌作用ン 本実施例もまだ本発明にか\る二価三価鉄の制癌作用を
示すものである。生理食塩を担体とする塩化鉄(II、
m)複合体を合成し、末期の胃癌患者に1日当り60ツ
宛経口的に適用した結果、次のような経過をたどり全面
的に回復した。
Example 10 (Anticancer effect) This example also shows the anticancer effect of divalent and trivalent iron according to the present invention.
m) The complex was synthesized and orally administered to a terminal stage gastric cancer patient at 60 doses per day, resulting in complete recovery with the following progress.

適用前症状:患者(♀、42才)の胃の幽門部に6cI
R×12aの腫瘍が形成され、撤去手術は不可能な状態
であったため、腫瘍はそのままとし、胃と腸とをチーー
ブで接続する手術だけを受けた。
Symptoms before application: 6cI in the pyloric region of the stomach of a patient (♀, 42 years old)
An R x 12a tumor had formed and removal surgery was not possible, so the tumor was left as is and only surgery was performed to connect the stomach and intestines with a tube.

適用後症状:1週目より体力の回復がみられ、3週目よ
り外出可能となり食事摂取量が増し体重増が与られた。
Symptoms after application: Recovery of physical strength was observed from the first week, and from the third week the patient was able to go out, increased food intake, and gained weight.

1ケ月後より通常の日常生活が営める状況となった。適
用以来肝臓諸機能は正常な状態を保っている。
One month later, the patient was able to lead a normal daily life. Since application, liver functions have remained normal.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は二価三価鉄塩を含む培養液における増殖指数を
示すものである。 図中−線は正常細胞 ・−・・線は異常細胞 特許出願人   山 下 昭 治
FIG. 1 shows the proliferation index in a culture solution containing divalent and trivalent iron salts. In the figure, lines indicate normal cells, lines indicate abnormal cells, patent applicant Shoji Yamashita

Claims (1)

【特許請求の範囲】 1、二価三価鉄塩 2、三価鉄塩を多量の強アルカリの水溶液に投入するこ
とを特徴とする二価三価鉄塩の製造方法 3、二価鉄塩を多量の強酸の水溶液に投入することを特
徴とする二価三価鉄塩の製造方法4、特許請求の範囲1
の二価三価鉄を担持した無機化合物 5、特許請求の範囲1の二価三価鉄を担持j〜だ有機化
合物
[Scope of Claims] 1. Divalent and trivalent iron salt 2. A method for producing a divalent and trivalent iron salt, which is characterized by adding the trivalent iron salt to a large amount of a strong alkali aqueous solution 3. Divalent iron salt Method 4 for producing a divalent and trivalent iron salt, characterized in that it is added to a large amount of an aqueous solution of a strong acid, Claim 1
An inorganic compound 5 carrying divalent and trivalent iron, and an organic compound carrying divalent and trivalent iron according to claim 1.
JP58064298A 1983-04-11 1983-04-11 Bivalent and trivalent iron salt and their preparation Granted JPS59190226A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP58064298A JPS59190226A (en) 1983-04-11 1983-04-11 Bivalent and trivalent iron salt and their preparation
JP1270700A JPH0761875B2 (en) 1983-04-11 1989-10-17 Method for producing active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58064298A JPS59190226A (en) 1983-04-11 1983-04-11 Bivalent and trivalent iron salt and their preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP1270700A Division JPH0761875B2 (en) 1983-04-11 1989-10-17 Method for producing active substance

Publications (2)

Publication Number Publication Date
JPS59190226A true JPS59190226A (en) 1984-10-29
JPH0427171B2 JPH0427171B2 (en) 1992-05-11

Family

ID=13254197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58064298A Granted JPS59190226A (en) 1983-04-11 1983-04-11 Bivalent and trivalent iron salt and their preparation

Country Status (1)

Country Link
JP (1) JPS59190226A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61247317A (en) * 1985-04-22 1986-11-04 日本植生株式会社 Soil for conditioning soil
JPS6354936A (en) * 1986-08-25 1988-03-09 Masami Oe Activated material
JPH01311007A (en) * 1988-06-08 1989-12-15 I B Ii:Kk Method for treating plant
JPH02113093A (en) * 1988-10-20 1990-04-25 Shizen:Kk Oil treating agent for food
JPH02167879A (en) * 1988-12-20 1990-06-28 Shizen:Kk Divalent-trivalent multiple iron salt formula fertilizer
JPH02208398A (en) * 1989-02-09 1990-08-17 Shizen:Kk Material for treating perfume
WO1991017957A1 (en) * 1990-05-22 1991-11-28 I.B.E. Co., Ltd. Ferrous salt composition
JPH0454101A (en) * 1990-06-25 1992-02-21 Tetsuo Takano Preservation of kidney for implantation and preserving device of same kidney
WO1995022254A1 (en) * 1994-02-17 1995-08-24 Merck Patent Gmbh Antiviral or antifungal composition and method
WO1995035113A1 (en) * 1994-06-20 1995-12-28 Thomas Bruns USE OF FERROUS (III) OXYDE (Fe2O3) FOR THE TREATMENT OF IMMUNE DEFICIENCIES ESPECIALLY AIDS
EP0896792A1 (en) * 1997-08-13 1999-02-17 Julphar Pharma GmbH Antiviral agent
WO2001047815A1 (en) * 1999-12-26 2001-07-05 Institute For State Physics Of Natural Materials Novel aqueous composition and use of the same
WO2001093879A1 (en) * 2000-06-06 2001-12-13 I.B.E. Co., Ltd. Biologically active agents and drugs

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6861264B1 (en) 2019-11-19 2021-04-21 慶昌 木島 Composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ENCYCLOPEDIA OF CHEMICAL REACTIONS=1951 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0246166B2 (en) * 1985-04-22 1990-10-15 Nippon Shokusei Kk
JPS61247317A (en) * 1985-04-22 1986-11-04 日本植生株式会社 Soil for conditioning soil
JPH0555182B2 (en) * 1986-08-25 1993-08-16 Hanyo Kagaku Kk
JPS6354936A (en) * 1986-08-25 1988-03-09 Masami Oe Activated material
JPH01311007A (en) * 1988-06-08 1989-12-15 I B Ii:Kk Method for treating plant
JPH02113093A (en) * 1988-10-20 1990-04-25 Shizen:Kk Oil treating agent for food
JPH02167879A (en) * 1988-12-20 1990-06-28 Shizen:Kk Divalent-trivalent multiple iron salt formula fertilizer
JPH02208398A (en) * 1989-02-09 1990-08-17 Shizen:Kk Material for treating perfume
WO1991017957A1 (en) * 1990-05-22 1991-11-28 I.B.E. Co., Ltd. Ferrous salt composition
JPH0454101A (en) * 1990-06-25 1992-02-21 Tetsuo Takano Preservation of kidney for implantation and preserving device of same kidney
WO1995022254A1 (en) * 1994-02-17 1995-08-24 Merck Patent Gmbh Antiviral or antifungal composition and method
US6187316B1 (en) 1994-02-17 2001-02-13 Merck Patent Gmbh Antiviral or antifungal composition and method
WO1995035113A1 (en) * 1994-06-20 1995-12-28 Thomas Bruns USE OF FERROUS (III) OXYDE (Fe2O3) FOR THE TREATMENT OF IMMUNE DEFICIENCIES ESPECIALLY AIDS
EP0896792A1 (en) * 1997-08-13 1999-02-17 Julphar Pharma GmbH Antiviral agent
WO1999008536A1 (en) * 1997-08-13 1999-02-25 Julphar Pharma Gmbh Antiviral agent
WO2001047815A1 (en) * 1999-12-26 2001-07-05 Institute For State Physics Of Natural Materials Novel aqueous composition and use of the same
WO2001093879A1 (en) * 2000-06-06 2001-12-13 I.B.E. Co., Ltd. Biologically active agents and drugs
AU2001262699B2 (en) * 2000-06-06 2006-05-04 I.B.E. Co., Ltd. Biologically active agents and drugs
KR100704566B1 (en) 2000-06-06 2007-04-06 유겐가이샤 아이.비.이 Method for treating iron salt

Also Published As

Publication number Publication date
JPH0427171B2 (en) 1992-05-11

Similar Documents

Publication Publication Date Title
JPS59190226A (en) Bivalent and trivalent iron salt and their preparation
JPH0363593B2 (en)
CN101400262A (en) Novel phytic citrate compounds and process for preparing the same
JP4598227B2 (en) Compounds that are sensitizers in radiation and chemotherapy and methods for their production and use
JP2003171215A (en) Fulvic acid-containing material, fulvic acid-containing composition, plant-activating agent, method for producing fulvic acid-containing material
JP6190445B2 (en) Benzene polycarboxylic acid compounds and their use as drugs
JPH01290606A (en) Plant growth promoter and production thereof
JP2713725B2 (en) Ethylenediamine compound-iron complex
JPH03187921A (en) Production of active substance
JPH05310728A (en) Preparation of modified huminate and its use
JP3723892B2 (en) Reduced antioxidant and method for producing the same
KR20210081711A (en) Manufacturing process of body fluid extract of sea squirt and the extract
TW541286B (en) Novel aqueous composition and use of the same
JPH0971528A (en) Antitumor agent
CN103304687A (en) Preparation of full-6-(3'S-tetrahydroisoquinolin-3'-formylamino)-6-deoxy-beta-cyclodextrin and application
CN108948140B (en) warfarin-4-O-acetyl-Arg-AA eleven compounds, and synthesis, activity and application thereof
RU2238735C1 (en) Agent for litholysis of urinary calculus and method for its preparing
JPH0380986A (en) Triiron tetroxide-containing water treatment agent
CN116458495A (en) Cell freezing solution for frozen storage of organoids and preparation method and application thereof
EP0230956B1 (en) Method for the recovery and for the production of a pasteurized alpha-2-antiplasmin preparation
JPS6181776A (en) Production of blue-green algae
JPS61158777A (en) Production of alga containing chromium
CN114698845A (en) Application of pachyman EGC composition in inhibiting formation of arginine pyrimidine in gastrointestinal tract
JP2001139478A (en) Extracted compound containing small amount mineral component from coral sand
JPH02302326A (en) Production of active substance